{"id":"NCT00614614","sponsor":"GlaxoSmithKline","briefTitle":"Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014","officialTitle":"Immunogenicity and Safety Study of a Booster Dose of GSK Biologicals' Meningococcal Vaccine 134612 Given at 12-15 Months of Age or at 15-18 Months of Age (Co-administered With Infanrix®) in Primed Healthy Toddlers.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-02-13","primaryCompletion":"2009-07-31","completion":"2009-09-17","firstPosted":"2008-02-13","resultsPosted":"2012-07-20","lastUpdate":"2018-09-21"},"enrollment":1558,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Infections, Meningococcal"],"interventions":[{"type":"BIOLOGICAL","name":"GSK Biologicals' Meningococcal vaccine GSK134612 (Nimenrix)","otherNames":["Nimenrix"]},{"type":"BIOLOGICAL","name":"GSK Biologicals' Hib-meningococcal vaccine GSK 792014 (Menhibrix)","otherNames":["Menhibrix"]},{"type":"BIOLOGICAL","name":"Infanrix®","otherNames":[]},{"type":"BIOLOGICAL","name":"ActHIB®","otherNames":[]},{"type":"BIOLOGICAL","name":"Pediarix®","otherNames":[]}],"arms":[{"label":"Menhibrix 1 Group","type":"EXPERIMENTAL"},{"label":"ActHIB- Infanrix Group","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to characterize the immunogenicity \\& safety of a booster dose of GSK Biologicals' meningococcal vaccine 134612 given at 12-15 months of age or at 15-18 months of age (co-administered with Infanrix®) in healthy toddlers primed with GSK Biological's Hib-meningococcal vaccine 792014. This study is single-blinded for the primary phase and open-label for the booster phase.","primaryOutcome":{"measure":"Number of Subjects With Serum Bactericidal Activity Using Human Complement (hSBA) Antibody Titers for N. Meningitidis Serogroups A(MenA), W-135(MenW-135), C(MenC) and Y(MenY) Greater Than or Equal to Protocol Specified Cut-off Value in Nimenrix 1 Group","timeFrame":"One month post vaccination at 12-15 months of age (Month 11)","effectByArm":[{"arm":"Nimenrix 1 Group","deltaMin":254,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Weeks","sex":"ALL","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":null},"locations":{"siteCount":56,"countries":["United States"]},"refs":{"pmids":["25305567","25152325"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":58,"n":1272},"commonTop":["Irritability","Redness","Drowsiness","Pain","Pain"]}}